This activity is expired and is no longer available for CME credit.


RVO: Assessing New Evidence on Anti-VEGF Treatment

Author(s)/Faculty: Carmen A. Puliafito, MD, MBA; Michael S Ip, MD; SriniVas R. Sadda, MD
Release Date: 3/8/2013Expiration Date: 3/7/2014
Credit Type: CMENumber of Credits: 0
Content Type: Provider:
Retinal vein occlusive disease is the second most common retinal vascular disease and is caused, in part, by uncontrolled VEGF. In this program, leading experts will discuss the pathophysiology and treatment of retina vein occlusive disease by controlling VEGF...